HackerTube.dev

Resveratrol – The Unfortunate (& Scandalous) Story

Dr Brad Stanfield · 207.8K views · 2022-02-12 · 18:39

Open on YouTube ↗

If playback is restricted in your region, try opening the original video. Use Mark watched to add it to your marked videos.

Overview

Dr Brad Stanfield recounts the research history and scandal around resveratrol, the supposed anti-aging supplement, including problems with the original studies.

On Hacker News

HN cites it for details on resveratrol's unreplicated original study and the related corporate deal.

Discussed on HN; no positive recommendation is recorded in this export · HN mentions 2022–2023

Topics

Fitness, sleep & longevityMedicine & infectious diseaseScientific method & science communication
Search by tags
resveratrolanti-agingsupplementsdavid sinclairreplication

What people said

Palmik · 2023-08 · Reference

Can you clarify about resveratrol? My understanding is that the original study had issues and wasn't reproduced. This video has some details: [VIDEO] I'm holding more hope for rapamycin, which was shown to prolong life span in mice in many studies.

Read the original HN comment ↗
altvali · 2023-05 · Reference

Not the person you're replying to, but this is what I found after a quick google search: Dr. Jeffrey Flier: [LINK] Dr. Charles Brenner: [LINK] Dr. Brad Stanfield: [VIDEO]

Read the original HN comment ↗
hourislate · 2022-02 · Reference

It's old news but did you know, He did fuck GSK for 750 million? Basically no one could ever replicate his study. GSK should have done thier homework so boohoo for them but still all is not what it seems. [VIDEO]

Read the original HN comment ↗

Sources

Video by Dr Brad Stanfield, played through YouTube.

Data and selection notes

HN summaries and labels may contain AI errors. HN dates refer to discussions, not video publication.

HN Library: HackerTube export (2026-10-31) and open-index/hacker-news. Upstream summaries and classifications may contain AI errors.

Views, duration and playback status refresh separately from the published catalog. When an update fails, existing data remains visible.

Selection checks
  • SaaS & AI candidates: Topic keywords do not match
  • Editor-approved picks: Editorial review is required

Rule matches identify candidates. They do not guarantee video quality or financial results.

About the library and its sources